Holmes Scott A

Avg. Two Year Performance

13% Avg. Purchase Return
6% Compound
63% Avg. Sale Return
28% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(13%)(22%)(14%)(21%)13%
Purchase Success Rate0 of 20 of 21 of 20 of 22 of 2
Average Sale Return(3%)12%54%59%63%
Sale Success Rate7 of 159 of 159 of 156 of 154 of 15

Keryx Biopharmaceuticals Inc.

Drugs » Drug Manufacturers - Major

Chief Financial Officer:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

AMAG Pharmaceuticals, Inc.

Drugs » Diagnostic Substances

SVP, Finance and Treasurer:

Holdings: 51.96K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--